LLY

1,040.97

+2.7%↑

JNJ

231.49

+0.92%↑

ABBV

214.52

+0.83%↑

UNH

382.43

-0.24%↓

AZN

189.76

+1.28%↑

LLY

1,040.97

+2.7%↑

JNJ

231.49

+0.92%↑

ABBV

214.52

+0.83%↑

UNH

382.43

-0.24%↓

AZN

189.76

+1.28%↑

LLY

1,040.97

+2.7%↑

JNJ

231.49

+0.92%↑

ABBV

214.52

+0.83%↑

UNH

382.43

-0.24%↓

AZN

189.76

+1.28%↑

LLY

1,040.97

+2.7%↑

JNJ

231.49

+0.92%↑

ABBV

214.52

+0.83%↑

UNH

382.43

-0.24%↓

AZN

189.76

+1.28%↑

LLY

1,040.97

+2.7%↑

JNJ

231.49

+0.92%↑

ABBV

214.52

+0.83%↑

UNH

382.43

-0.24%↓

AZN

189.76

+1.28%↑

Strona główna・Stock List・NeoGenomics Inc

NeoGenomics Inc

Closed

9.11 3.17

Buy Sell

Overview

Share price change

24h

Current

Min

8.54

Max

9.11

Key metrics
By Trading Economics
Income	-7.2M -17M
Sales	-3.5M 187M
EPS	0.01
Profit margin	-9.164
Employees	2,500
EBITDA	-5.8M -567K

Recommendations
By TipRanks
Recommendations	Buy
12 Months Forecast	+67.75% upside

Dividends
By Dow Jones
Next Earnings	28 lip 2026

Market Stats
By TradingEconomics
Market Cap	-31M 1.1B
Previous open	5.94
Previous close	9.11

Technical Score

By Trading Central

Confidence

Very Strong Bearish Evidence

7.7 / 10.27 Support & Resistance

NeoGenomics Inc Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

18 maj 2026, 10:01 UTC

Major Market Movers

Bitcoin Depot Shares Tumble Premarket on Bankruptcy Filing, Plans to Shut Down

15 maj 2026, 16:02 UTC

Earnings

Major Market Movers

Forward Industries Shares Fall on New Debt as Solana Value Drops

15 maj 2026, 03:37 UTC

Acquisitions, Mergers, Takeovers

Hana Bank to Buy $670 Million Stake in Crypto Exchange Operator Dunamu

20 maj 2026, 17:08 UTC

Market Talk

Zcash Benefiting From Investments in 'Production-Grade Privacy' -- Market Talk

20 maj 2026, 16:20 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

20 maj 2026, 15:51 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

20 maj 2026, 15:51 UTC

Market Talk

Zcash Tears Higher in Mostly Positive Day for Crypto -- Market Talk

20 maj 2026, 15:39 UTC

Market Talk

Bitcoin Support Seen as $76k, Says Bitfinex -- Market Talk

20 maj 2026, 13:08 UTC

Market Talk

Bitcoin Rangebound as ETF Outflows Continue -- Market Talk

20 maj 2026, 12:44 UTC

Market Talk

Bitcoin Gains Slightly as U.S. Stock Futures Rise -- Market Talk

20 maj 2026, 07:25 UTC

Market Talk

Bitcoin Edges Higher But Iran War Uncertainty Limits Gains -- Market Talk

19 maj 2026, 16:20 UTC

Market Talk

Financial Services Roundup: Market Talk

19 maj 2026, 15:54 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

19 maj 2026, 15:54 UTC

Market Talk

Bitcoin Holders Under Little Pressure to Sell Despite ETF Outflow -- Market Talk

19 maj 2026, 14:51 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

19 maj 2026, 14:51 UTC

Market Talk

Ethereum Down From Near-Term High -- Market Talk

19 maj 2026, 08:26 UTC

Market Talk

Bitcoin Edges Higher as Oil Price, Bond Yields Fall -- Market Talk

19 maj 2026, 08:26 UTC

Market Talk

Market Talk Roundup: Latest on U.S. Politics

18 maj 2026, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

18 maj 2026, 17:22 UTC

Market Talk

Tokenized Assets Expected to be Over $1T By 2030 -- Market Talk

18 maj 2026, 15:23 UTC

Market Talk

Crypto Market Index Returns to Fear Reading -- Market Talk

18 maj 2026, 14:36 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

18 maj 2026, 14:36 UTC

Market Talk

Cryptocurrencies Down as Rate Cut Hopes Fade -- Market Talk

18 maj 2026, 07:25 UTC

Market Talk

Bitcoin Falls as Iran War, U.S. Rate Rise Bets Weigh -- Market Talk

15 maj 2026, 16:20 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

15 maj 2026, 13:19 UTC

Market Talk

Bitcoin Hits Resistance Despite Clarity Act Progress -- Market Talk

15 maj 2026, 12:49 UTC

Market Talk

Bitcoin Falls on Risk Aversion, Stronger Dollar -- Market Talk

15 maj 2026, 08:47 UTC

Market Talk

Bitcoin Falls on Iran War Tensions, U.S. Rate-Rise Bets -- Market Talk

14 maj 2026, 23:57 UTC

Acquisitions, Mergers, Takeovers

Kakao: Stake Sales Aim to Secure Funds for Future Investments

14 maj 2026, 23:56 UTC

Acquisitions, Mergers, Takeovers

Kakao: Share Sale to Lower Kakao Investment's Stake in Dunmau to 4.03%

Peer Comparison

Price change

NeoGenomics Inc Forecast

Price Target

By TipRanks

67.75% upside

12 Months Forecast

Average 14.93 USD 67.75%

High 25 USD

Low 11 USD

Based on 10 Wall Street analysts offering 12 month price targets forNeoGenomics Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

10 ratings

Buy

Hold

Sell

Based on 10 analysts giving stock ratings to NeoGenomics Inc - Dist in the past 3 months.

Technical Score

By Trading Central

7.7 / 10.27Support & Resistance

Recent bearish events outweigh bullish events.

All events are bearish.

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

About NeoGenomics Inc

NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. It operates through Clinical Services and Advanced Diagnostics segments. The company offers testing services to hospitals, academic centers, pathologists, oncologists, clinicians, pharmaceutical companies, and clinical laboratories. It also provides cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; and immunohistochemistry and digital imaging testing services to localize cellular proteins in tissue section, as well as to allow clients to visualize scanned slides, and perform quantitative analysis for various stains. In addition, the company also provides molecular testing services, which focus on the analysis of DNA and/or RNA, and the structure and function of genes at the molecular level; morphologic analysis, which is the process of analyzing cells under the microscope by a pathologist for the purpose of diagnosis; and testing services in support of its pharmaceutical clients' oncology programs covering discovery and commercialization. NeoGenomics, Inc. was founded in 2001 and is headquartered in Fort Myers, Florida.